Pay in 4 interest-free payments of $10.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
by using three different mouse and human islet in vivo-based models
is a selective LIM kinase 2 (LIMK2) inhibitor
Epub 2016 Nov 11
Ishikawa tumors have higher apoptotic indices than Hec1A tumors after treatment with GSK2256098
PAI-039 - CAS# 393105-53-8 size:2mg solid by using three different mousePAI 039, CAS No. 393105 53 8, is a novel plasminogen activator inhibitor 1 (PAI 1) inhibitor. The pharmacokinetic profile of PAI 039 indicated an oral bioavailability of 43 + 15. 3% and a plasma half life of 6. 2 + 1. 3 h. PAI 039 is an orally active prothrombolytic drug that inhibits PAI 1 and accelerates fibrinolysis while maintaining normal coagulation in a model of coronary occlusion . PAI 039 exerts antithrombotic efficacy in rat models of